Market Research Report
Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Japan | 2018
|Published by||Millennium Research Group - DRG||Product code||646046|
|Published||Content info||106 Pages
Delivery time: 1-2 business days
|Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Japan | 2018|
|Published: May 31, 2018||Content info: 106 Pages||
The mature Japanese CRM device market will remain flat through 2026, characterized by low generator unit volume growth, rising ICM procedure volumes, and price erosion. The uptake of premium-priced devices such as CRT devices, leadless pacemakers, and S-ICDs will help mitigate the downward pressure of reimbursement cuts over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese cardiac rhythm management device market across a 10-year period.
What is the predicted uptake of novel devices such as leadless pacemakers and S-ICDs? Will leadless pacemakers and S-ICDs become the standard of care?
To what extent does the uptake of leadless pacemakers like Medtronic's Micra and Boston Scientific's EMBLEM S-ICDs offset declining revenue in other markets?
New-generation miniature ICMs like Medtronic's Reveal LINQ have experienced strong uptake, how does this affect competitive standings? Have other ICM competitors met Medtronic's challenge? How does the availability of this device affect sales of other CRM devices?
How do epidemiological trends and new technology influence growth in different pulse generator product segments? How are these trends different compared to the rapidly expanding ICM market?
How can individual competitors realize growth in this large but fairly mature market?
How are the MHLW's biennial reimbursement revisions different between device segments? What 2018 revisions will affect market growth?
How are the ASP trends for novel devices different compared to those for more established devices?